Introduction
The introduction of the current generation of multidetector CT (MDCT) scanners with improved temporal and spatial resolution has allowed noninvasive imaging of coronary arteries and provides information on other cardiac structures and their function. These include left and right ventricular function and structure, atrial anatomy, cardiac and pulmonary venous systems assessment, and the pericardium. Evaluation of these structures is important in the assessment and management of heart failure (HF) patients. With increased utilization of devices in HF such as implantable cardioverter defi brillators (ICDs) and pacemakers and subsequent limitation of the use of MRI, cardiac MDCT allows an alternative noninvasive option for assessing these patients. Over the last decade, the four-slice MDCT system technology and software innovations evolved to eight-and 16-slice to the current 64-slice MDCT system in 2004. The system refi nements include increased gantry rotation speed combined with electrocardiogram-gated images, allowing cardiac phase-correlated image reconstruction retrospectively for specifi ed images during desired phases of the cardiac cycle.
Scanning Patients With HF

Breath-hold
Via simultaneous acquisition of 64 parallel cross-sections, image acquisition time is now reduced to 10 to 15 seconds. During this time, patients hold their breath to minimize motion artifact, and this short timeframe for breath-hold makes it possible to achieve good image quality. For most patients with respiratory and cardiac comorbidities, this is feasible.
Radiation exposure
The radiation exposure of MDCT is between 5 and 20 mSv, which is comparable to several other imaging modalities, such as nuclear perfusion tests.
Contrast exposure
Iodinated contrast requirement is typically between 60 and 100 mL for coronary vessel visualization; this may be affected by patient size and scanner type. Because renal dysfunction is prevalent in HF, exposure to contrast media needs special consideration and may limit MDCT use in some patients.
Intravenous β-blockers
The administration of β-blockers intravenously is common prior to MDCT scanning; this may be problematic in some HF patients with low blood pressure. However, most HF patients are likely to be already taking these drugs orally, and lower heart rates at baseline may obviate the need for intravenous β-blockers.
Cardiovascular Evaluation in HF
Left ventricle
Evaluation of the left ventricular structure and function, specifi cally ejection fraction, is an integral step in Common clinical practice utilizes two-dimensional echocardiography, a modality that is easily obtained and has no risks. Limitations of echocardiography, however, are inadequate image quality in some patients resulting from body habitus and the inherent geometric assumptions necessary for calculations. MRI is the gold standard for cardiac structure and function evaluation secondary to its excellent spatial resolution, accuracy, and reproducibility of measurements without any geometric assumptions. However, due to the duration and multiple prolonged breath-holds required to obtain adequate images, inability to perform the study in patients with devices, and claustrophobia in some patients, MRI is not always feasible.
Left ventricular volume calculation
Left ventricular volume measurements by MDCT are based on short-axis image reformations (similar to MRI and echocardiography). At the midventricular level, a single image is reconstructed every 5% of the R-R interval to obtain both a diastolic and systolic phase. Appropriate reconstruction windows are identifi ed at the points of the minimum ventricular diameter (approximately 25% of the R-R interval) and the maximum ventricular diameter (approximately 85% of the R-R interval) [2•]. Left ventricular volume can be measured using two approaches. In the Simpson method (also used in MRI), left ventricular volume is calculated by adding all cross-sectional areas of equal width (obtained from contiguous, shortaxis images of the left ventricle) multiplied by the section thickness. Despite cumbersome calculation, the Simpson method is quite accurate as it has no reliance on geometric assumptions [3] . The threshold-based, direct-volume measurement method uses a segmentation technique that detects density or signal intensity differences between contrast-fi lled cardiac chambers and the myocardium. Using a predefi ned attenuation threshold, the sum of contiguous voxels greater than this threshold is defi ned as the total chamber volume [4] .
Juergens and Fischbach [4] summarized data from 18 studies. They compared MDCT (including four-to 16-slice MDCT) to cine ventriculography, two-dimensional echocardiography, and MRI, specifi cally evaluating left ventricular end-diastolic volumes, left ventricular endsystolic volumes, and ejection fraction. The correlation coeffi cients differed minimally among the various studies: left ventricular end-diastolic volume was 0.86 to 0.99, left ventricular end-systolic volume was 0.90 to 0.99, and ejection fraction was 0.80 to 0.99. In another study, 16-slice MDCT was compared with MRI for assessment of left ventricular wall function in a group of patients with high prevalence of wall motion abnormalities, including those with previous myocardial infarction, arrhythmogenic right ventricular cardiomyopathy, and dilated cardiomyopathy. Concordance coeffi cients for the volumes were as follows: left ventricular end-diastolic volume, p c = 0.96; left ventricular end-systolic volume, p c = 0.943; and left ventricular stroke volume, p c = 0.939. Correlation for left ventricular ejection fraction was moderate (p c = 0.835), with a mean difference and standard deviation of -2.5 ± 4.2 (P = 0.02). Wall motion abnormalities correlated well between modalities, with MDCT and MRI in agreement in 416 of 480 segments (86.7%). However, the correlation was weaker in segments with wall motion impairment; MDCT had the tendency to underestimate the degree of impairment compared with MRI [5] .
The fi ndings of lower ejection fraction (likely contributed to by overestimation of the mean left ventricular end-diastolic volume/left ventricular end-systolic volume secondary to temporal resolution timing issues with the four-and 16-slice CT) are described in other studies [6] . One study specifi cally compared the evaluation of left ventricular contractile function via percent systolic wall thickening in MDCT versus wall motion index by transthoracic echocardiography. A signifi cant inverse linear correlation was noted between regional myocardial systolic wall thickening and wall motion index by transthoracic echocardiography (r = -0.8; P < 0.001). Using receiver operating characteristic analysis, the area under the curve was 0.83 (95% CI = 0.80-0.87) to differentiate normal and dysfunctional myocardial segments (wall motion score > 1). For systolic wall thickening, 40% was the optimal cutoff resulting in sensitivity of 76% and specifi city of 78%. Systolic wall thickening demonstrated patients with global left ventricular systolic dysfunction with high diagnostic accuracy, including sensitivity of 92% and specifi city of 98% for identifi cation of patients with wall motion index greater than 1.5. Even in this study with 64-slice CT, overestimation of left ventricular ejection fraction, end-diastolic volume, and end-systolic volume was seen and was statistically signifi cant (4.8% with 95% lines of agreement ranging from -8.8% to 18.3%, P < 0.001 for all three measurements), but with overall strong correlation of r = 0.85 (P < 0.001) for end-diastolic volume and r = 0.93 (P < 0.001) for end-systolic volume [7] . Butler and colleagues [8] compared 64-slice MDCT in HF patients specifi cally with transthoracic echocardiography. Correlations with volumes reported were as follows: left ventricular end-diastolic volume, 0.62; left ventricular end-systolic volume, 0.67; and stroke volume, 0.60; all P values were more than 0.15. In this cohort of depressed ejection fraction (mean ejection fraction 36% ± 8% with echocardiography, versus 38% ± 12% by MDCT; r = 0.67, P = 0.28), wall thickness (r = 0.76) and regional wall motion assessment were not signifi cantly different by the two techniques [8] . Overall, MDCT appears to correlate well with both MRI and transthoracic echocardiography for left ventricular assessment and has been specifi cally evaluated recently in HF patients. However, clinicians need to be aware that MDCT-derived values for volumes and ejection fraction are slightly, yet systematically, higher compared with transthoracic echocardiography-derived values. It is worth noting that MDCT is a true volumetric method; remodeling of the chambers should not infl uence the accuracy. Figure 1 depicts structural remodeling in a patient with dilated cardiomyopathy with a
